Posted inBusiness Insights
Granules India Warns US Tariff Plans Cannot Easily Overcome High Domestic Drug Manufacturing Costs
Indian pharmaceutical major Granules India announced from its Hyderabad headquarters that relocating large-scale generic drug manufacturing to the United States remains highly impractical due to steep domestic operating costs, despite…
